Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Long-term visual outcome and its predictive factors following treatment of acute submacular hemorrhage with intravitreous injection of tissue plasminogen factor and gas.

Sobolewska B, Utebey E, Bartz-Schmidt KU, Tatar O.

J Ocul Pharmacol Ther. 2014 Sep;30(7):567-72. doi: 10.1089/jop.2013.0135. Epub 2014 May 12.

PMID:
24821566
2.

Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.

Hattenbach LO, Klais C, Koch FH, Gümbel HO.

Ophthalmology. 2001 Aug;108(8):1485-92.

PMID:
11470706
3.

Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.

Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, Blodi BA, Elner SG.

Ophthalmology. 1999 Oct;106(10):1900-6; discussion 1906-7.

PMID:
10519583
4.

Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.

Kung YH, Wu TT, Hong MC, Sheu SJ.

J Ocul Pharmacol Ther. 2010 Oct;26(5):469-74. doi: 10.1089/jop.2010.0066.

PMID:
20925578
5.

Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.

Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.

Am J Ophthalmol. 2014 Jun;157(6):1250-7. doi: 10.1016/j.ajo.2014.02.007. Epub 2014 Feb 13.

PMID:
24531021
6.

Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.

Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.

Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):5-11. doi: 10.1007/s00417-009-1158-7. Epub 2009 Aug 11.

PMID:
19669780
7.

Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.

Haupert CL, McCuen BW 2nd, Jaffe GJ, Steuer ER, Cox TA, Toth CA, Fekrat S, Postel EA.

Am J Ophthalmol. 2001 Feb;131(2):208-15.

PMID:
11228297
8.

[Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].

Hattenbach LO, Brieden M, Koch F, Gümbel H.

Klin Monbl Augenheilkd. 2002 Jul;219(7):512-8. German.

PMID:
12195317
9.

Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.

Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS.

Arch Ophthalmol. 2001 Jan;119(1):28-32.

PMID:
11146723
10.

Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.

Fang IM, Lin YC, Yang CH, Yang CM, Chen MS.

Eye (Lond). 2009 Feb;23(2):397-406. Epub 2007 Nov 2.

PMID:
17975562
11.

Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.

Treumer F, Roider J, Hillenkamp J.

Br J Ophthalmol. 2012 May;96(5):708-13. doi: 10.1136/bjophthalmol-2011-300655. Epub 2011 Dec 15.

PMID:
22174095
13.
14.

Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.

Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC.

Ophthalmology. 2004 Jun;111(6):1201-8. Erratum in: Ophthalmology. 2004 Sep;111(9):1640.

PMID:
15177972
15.

Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.

Papavasileiou E, Steel DH, Liazos E, McHugh D, Jackson TL.

Retina. 2013 Apr;33(4):846-53. doi: 10.1097/IAE.0b013e318271f278.

PMID:
23400079
16.
17.

Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.

Guthoff R, Guthoff T, Meigen T, Goebel W.

Retina. 2011 Jan;31(1):36-40. doi: 10.1097/IAE.0b013e3181e37884.

PMID:
20921929
18.

Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas.

Lee JP, Park JS, Kwon OW, You YS, Kim SH.

Korean J Ophthalmol. 2016 Jun;30(3):192-7. doi: 10.3341/kjo.2016.30.3.192. Epub 2016 May 18.

19.
20.

Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.

Inoue M, Shiraga F, Shirakata Y, Morizane Y, Kimura S, Hirakata A.

Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1663-9. doi: 10.1007/s00417-014-2861-6. Epub 2014 Nov 25.

PMID:
25418034

Supplemental Content

Support Center